Grape Polyphenols May Prevent High-Fat Diet-Induced Dampening of the Hypothalamic-Pituitary-Adrenal Axis in Male Mice
Overview
Authors
Affiliations
Context : Chronic high-fat diet (HFD) consumption causes obesity associated with retention of bile acids (BAs) that suppress important regulatory axes, such as the hypothalamic-pituitary-adrenal axis (HPAA). HFD impairs nutrient sensing and energy balance due to a dampening of the HPAA and reduced production and peripheral metabolism of corticosterone (CORT).
Objective: We assessed whether proanthocyanidin-rich grape polyphenol (GP) extract can prevent HFD-induced energy imbalance and HPAA dysregulation.
Methods: Male C57BL6/J mice were fed HFD or HFD supplemented with 0.5% w/w GPs (HFD-GP) for 17 weeks.
Results: GP supplementation reduced body weight gain and liver fat while increasing circadian rhythms of energy expenditure and HPAA-regulating hormones, CORT, leptin, and PYY. GP-induced improvements were accompanied by reduced mRNA levels of , , and in ileal or hepatic tissues and lower cecal abundance of Firmicutes, including known BA metabolizers. GP-supplemented mice had lower concentrations of circulating BAs, including hydrophobic and HPAA-inhibiting BAs, but higher cecal levels of taurine-conjugated BAs antagonistic to farnesoid X receptor (FXR). Compared with HFD-fed mice, GP-supplemented mice had increased mRNA levels of hepatic and , suggesting reduced FXR activation and more BA synthesis. GP-supplemented mice also had reduced hepatic and ileal and , indicative of less BA transfer into enterocytes and circulation. Relative to HFD-fed mice, CORT and BA metabolizing enzymes ( and ) were increased, and was decreased in GP supplemented mice.
Conclusion: GPs may attenuate HFD-induced weight gain by improving hormonal control of the HPAA and inducing a BA profile with less cytotoxicity and HPAA inhibition, but greater FXR antagonism.
Neuroprotective effect of niacin in a rat model of obesity induced by high-fat-rich diet.
Manzoor N, Samad N, Bhatti S, Irfan A, Ahmad S, Shazly G Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39680102 DOI: 10.1007/s00210-024-03687-3.
Mezhibovsky E, Tveter K, Villa-Rodriguez J, Bacalia K, Kshatriya D, Desai N J Endocr Soc. 2023; 7(9):bvad095.
PMID: 37538101 PMC: 10396072. DOI: 10.1210/jendso/bvad095.